Intergalactic Therapeutics

Intergalactic Therapeutics, founded by leading life science venture capital firm ATP (Apple Tree Partners), aims to overcome the limitations of virus-based gene therapies and develop first-class non-viral alternatives. Intergalactic utilizes synthetic biology and engineered gene circuits to create covalently closed and circular DNA (“C3 DNA”) molecules, aiming to provide patients with safer and more effective solutions.